Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 8489 - 8496 of 12089 results

Mintz’s Employment Matters Blog Covers Supreme Court Ruling in ERISA Case
March 14, 2016| Blog| Viewpoint

What are the USPTO’s Patent Plans for Fiscal Year 2017?
March 14, 2016| Blog| Viewpoint

Report Calls for More Guidance on Medicaid Hospital Payments
March 14, 2016| News

Why Life Sciences Leases Are Not Your Average Transaction
March 14, 2016| News

Massachusetts Legislature Reaches Compromise on Opioid Legislation
March 11, 2016| Alert| Viewpoint

Massachusetts SJC Lightens Plaintiffs’ Summary Judgment Burden in Employment Discrimination Cases
March 11, 2016| Blog| Viewpoint

Amarin/FDA Settlement: A Significant First Amendment Victory for Off-Label Marketing
March 11, 2016| Blog| Viewpoint

BPCIA Patent Litigation Webinar Recap
March 11, 2016| Blog| Viewpoint
News & Press Releases
Mintz advised the creators of Morbid, one of the top-charting true crime podcasts, in a multi-year agreement to move to SiriusXM from Wondery. The deal gives SiriusXM exclusive advertising rights for the audio and video formats of the podcast.
Mintz Advises CVC DIF in Acquisition of SBA Communications’ Canadian Tower Infrastructure Platform
August 06, 2025
Mintz advised CVC DIF, the dedicated infrastructure investment strategy of global private markets manager CVC, in its agreement to acquire SBA Communications’ Canadian wireless tower business, one of Canada’s leading independent owners and operators of wireless communications towers. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions.
Mintz advised the underwriters in connection with a $69 million public offering by Larimar Therapeutics, Inc. of 21,562,500 shares of its common stock at a price to the public of $3.20 per share. The gross proceeds to Larimar from the offering were $69 million before deducting underwriting discounts and commissions and other offering expenses.
Events
Podcasts

Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|

Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
